Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

26.03 +0.33 (+1.28%)

Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Pfizer (PFE) Q3 2025 Earnings Call Transcript ↗

November 04, 2025

Pfizer (PFE) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion ↗

November 04, 2025

Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked bid.

Via Investor's Business Daily

Dow Dips Over 400 Points; Pfizer Earnings Top Estimates ↗

November 04, 2025

Via Benzinga

Topics Stocks

Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters ↗

November 04, 2025

Metsera said that it would be entitled to terminate its merger agreement with Pfizer if Novo’s proposal continues to be superior.

Via Stocktwits

Pfizer's Core Drugs Offset COVID Revenue Drop, Lifts 2025 Profit Outlook Despite Tariffs ↗

November 04, 2025

Pfizer beat Q3 estimates with 87 cents EPS, raised 2025 profit guidance, as Eliquis and Vyndaqel growth offset declining COVID product sales.

Via Benzinga

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Novo Nordisk Q3 Preview: Analysts See Profit Drop As Obesity Market Cools, Pfizer Tensions Rise ↗

November 04, 2025

Via Stocktwits

Check Out What Whales Are Doing With PFE ↗

November 03, 2025

Via Benzinga

Pfizer’s (NYSE:PFE) Q3 Earnings Results: Revenue In Line With Expectations

November 04, 2025

Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year...

Via StockStory

Pfizer Raises Profit Outlook Even As Third-Quarter Sales Decline ↗

November 04, 2025

Pfizer beat third-quarter expectations Tuesday, though both sales and profit fell year over year. The company also hiked its profit view.

Via Investor's Business Daily

Is Eli Lilly a Millionaire Maker? ↗

November 04, 2025

Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.

Via The Motley Fool

Topics Intellectual Property

Zoetis (NYSE:ZTS) Reports Q3 In Line With Expectations But Stock Drops

November 04, 2025

Animal health company Zoetis (NYSE:ZTS) met Wall Streets revenue expectations in Q3 CY2025, but sales were flat year on year at $2.4 billion. On the other hand, the company’s full-year revenue guidance...

Via StockStory

The Battle For Metsera Acquisition Heats Up As Pfizer Files A Second Lawsuit ↗

November 03, 2025

Via Stocktwits

Pfizer Inc (NYSE:PFE) Reports Q3 2025 Earnings Beat and Raises Full-Year Profit Guidance ↗

November 04, 2025

Pfizer Q3 2025 earnings beat estimates and the company raised its full-year profit guidance, highlighting strong cost management and non-COVID portfolio growth.

Via Chartmill

Topics Earnings

Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat Street Estimates ↗

November 04, 2025

The company noted that it is on track to deliver about $7.2 billion in overall anticipated net cost savings by the end of 2027.

Via Stocktwits

Topics Artificial Intelligence World Trade

Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance

November 04, 2025

From Pfizer Inc.

Via Business Wire

Pfizer Tops EPS Expectations In Q3 2025 Despite Revenue Decline ↗

November 04, 2025

Pfizer reported Q3 2025 revenue of $16.7 billion and adjusted EPS of $0.87, beating expectations and prompting a full-year EPS guidance raise.

Via Talk Markets

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

November 04, 2025

With yields of up to 7%, this trio of high-yield stocks are all industry-leading companies.

Via The Motley Fool

Topics Energy Stocks

Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

November 04, 2025

Via Benzinga

Uber, AMD And 3 Stocks To Watch Heading Into Tuesday ↗

November 04, 2025

Stock futures trading lower, watch Uber, Upwork, AMD, Starbucks, Pfizer earnings. Starbucks forms China JV. Cramer advises against AT&T.

Via Benzinga

Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts ↗

November 03, 2025

Michael Burry's Scion Asset Management filed an updated 13F showing a new large bearish position in Palantir and Nvidia, among others.

Via Benzinga

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. ↗

November 03, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Monday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

Tech Titans Unite and Consumer Giants Merge: Amazon-OpenAI Partnership and Kenvue Buyout Ignite S&P 500 and Nasdaq Gains

November 03, 2025

November 3, 2025 – The U.S. stock markets are experiencing a significant surge today, with both the S&P 500 and Nasdaq Composite pushing towards new highs. This bullish sentiment is largely fueled by...

Via MarketMinute

Topics Artificial Intelligence Lawsuit Stocks

Did Novo Nordisk Just Say "Checkmate" to Pfizer? ↗

November 03, 2025

These two leading drugmakers are fighting over a promising GLP-1 candidate.

Via The Motley Fool

Topics Intellectual Property

Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo ↗

November 03, 2025

Metsera called Pfizer's claims "nonsense" in a follow-up Monday to Pfizer's lawsuit against Metsera and Novo Nordisk.

Via Investor's Business Daily

Topics Economy Lawsuit

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership ↗

November 03, 2025

BioNTech reports a Q3 loss but boosts 2025 revenue forecast to €2.6–2.8 billion, driven by Bristol Myers collaboration and cost optimization.

Via Benzinga

Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle ↗

November 03, 2025

Pfizer sues Metsera and Novo Nordisk, alleging breach of contract and antitrust violations over a rival $9 billion bid challenging its $4.9 billion merger deal.

Via Benzinga

Topics Lawsuit

Insights Ahead: Pfizer's Quarterly Earnings ↗

November 03, 2025

Via Benzinga

2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon ↗

November 03, 2025

The healthcare industry is chock-full of opportunities for long-term investors.

Via The Motley Fool

Topics Government World Trade

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.